Author:
Gairola Anurag,Biswas AmitKumar,Baranwal AjayKumar,Jagani Rajat,Pawar AmitAjay,Dimri Ujjwal
Reference18 articles.
1. Nooka AK, Kaufman JL, Hofmeister CC, Joseph NS, Heffner TL, Gupta VA, et al. Daratumumab in multiple myeloma. In: Cancer. Vol. 125. American Cancer Society: John Wiley and Sons Inc.; 2019. p. 2364-82.
2. Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma;Quach;Intern Med J,2018
3. CD38 antibodies in multiple myeloma: Mechanisms of action and modes of resistance;van;Front Immunol,2018
4. Epidemiology, staging, and management of multiple myeloma;Padala;Med Sci (Basel),2021
5. An evaluation of subcutaneous daratumumab for the treatment of multiple myeloma;Paul;Expert Rev Hematol,2020